CytomX Therapeutics, Inc. (FRA:6C1)
Germany · Delayed Price · Currency is EUR 4.580
+0.082 (1.82%)
Last updated: Feb 20, 2026, 8:00 AM CET
515.59% (1Y)
| Market Cap | 780.93M +1,008.7% |
| Revenue (ttm) | 96.85M -10.3% |
| Net Income | 23.88M +102.6% |
| EPS | 0.20 +50.2% |
| Shares Out | n/a |
| PE Ratio | 32.70 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 88 |
| Open | 4.580 |
| Previous Close | 4.498 |
| Day's Range | 4.580 - 4.580 |
| 52-Week Range | 0.384 - 5.055 |
| Beta | n/a |
| RSI | 54.39 |
| Earnings Date | Mar 6, 2026 |